本文へスキップ

ナノサプリメントの研究 開発 製造

お問合せはTEL.048-775-3408

Nanomedical Center

Nanomedical Center

Setting the goal to establish health of human being, we expand business with integration of western and oriental medicine. We have been developing research for ethics of chinese medicine and chinese herbal medicine, collection of cutting edge medical information including western medicine, and genetic level analysis from cell to molecule medicine. With the point of view of "Ishokudougen";food and medicine have the same origin, we provide with theme of improvement of diet and living healthy and long life, we will strive to develop the latest and highest quality of health food for the sake of well- being of people.

"It's already too late if you start treatment after getting illness.

Based on this idea, we regard prevention as the most important.
Tian Li Medical Institute offers health seminers, nutrition forum, and beauty salon that play a leading role in terms of maintenance, promoting, and recovering health as well as QOL improvement. We hope some of advices on health will be of your help.

Please feel free to E-mail us if you have any questions or comments.

Contents

1 Research of chinese medicine
2 Providing the latest information on chinese herbal medicine
3 Development and consulting of semi-finished or finished products of health natural foods.
4 Implementation of demonstration experiment based on industry‐government‐university collaboration, development of new business, and introduction of successful test cases.
 


 Concrete examples
   Taking out DNA from human salivary
   Planning of course of lectures and seminars
   Quality inspection of materials, semi-finished and finished products
   Interaction of oriental and western medical scientists
   Social contribution activities






Research Achievements

【Published in magazines】
  1. " Mechanism of Pulmonary Surfactant Secretion in the Aging Process --- Correlation between Ultrastructure of Clara Cell and Changes of Surfactant Material in BAL(Broncho-Alveolar-Lavage) Fluid in the Cholerterol-Fed Rabbits---". Journal of Clinical Electron Microscopy. vol. 22, no. 5-6, 1989, p. 872.
      Heng Zheng, Hiroshi Kobayashi, Yasuhisa Hirohata, Kaoru Aihara. Central Institute for Electron Microscopic researches, WHO Collaborating Center for Research and Training in Diagnostic Electron Microscopy, Nippon Medical School.
  2. "Effect of Amizet Solution in the Endotoxin-Treated Hepatic Failure". Journal of Clinical Electron Microscopy. vol. 22, no. 5-6, 1989, p. 758-759.
     Yasuhisa Hirohata, Hiroshi Kobayashi, Je Pan, Heng Zheng, Kaoru Aihara. Central Institute for Electron Microscopic researches, WHO Collaborating Center for Research and Training in Diagnostic Electron Microscopy, Nippon Medical School.
  3. "Nasal NK-cell Lymphoma". The Japanese Jounal of Clinical Hematology. vol.35, no.6, 1994, p.588-592.
     Junko Fukuda*1 ; Toshio Yoshihara*2 ; Yukari Arai*1 ; Takako Kaneko*1 ; Heng Zheng*3 ; Shigeo Mori*3 ; Masako Aoyama*1 ; Michihiko Masuda*1 ; Toshiko Motoji*1 ; Kazuo Oshimi*1 ; Hideaki Mizoguchi*1
    ( *1 = Tokyo Women's Medical College, Dep. of Hematology, *2 = Tokyo Women's Medical College, Dep. of Otolaryngology, *3 = The Institute of Medical Science, The Univ.of Tokyo, Dep. of Pathology).
  4. "Nasal natural killer(NK) cell lymphoma report of a case with activated NK cells containing Epstein-Barr virus and expressing CD21 antigen, and comparative studies of their phenotype and cytotoxicity with normal NK cells". Brithish Journal of Haematology, 1995, 91, p.355-361.
     Takako Kaneko *1, Junko Fukuda *1, Toshio Yoshihara *2, Heng Zheng *3, Shigeo Mori *3, Hideaki Mizoguchi *2, and Kazuo Oshimi *1.

    ( *1 = Department of Medicine, Division of Haematology, Juntendo University School of Medicine, Tokyo. *2 = Departments of Otolaryngology and Haematology, Tokyo Women's Medical College, Tokyo. *3 = The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.)
  5. "Epstein-Barr virus infected lymphocytes in non-neoplastic lymph nodes of patients infected with human immunodeficiency virus".
    Heng Zheng, Shigeo Mori. Dept. of Pathol, Inst. of Med. Sci. Univ. of Tokyo, Japan.
    Pathology international. vol.47, 1997, p.217-221.
    click here
  6. "Analysis of Epstein-Barr virus infected cell in human immunodeficiency virus infected patients".
    Chinese medical journal. (Electronic Edition)
    www.cmj.org (net prints) vol.114, No.3 (22), 2001.
    Heng Zheng. Dept. of Pathol, Tianli Medical Institute.
    click here
  7. "Analysis of brain cell activation by nanosized particles of Ginkgo biloba extract" --------------------------------
    Shimada Shinji, Tanaka Yasukazu, Waki Hatsue, Kon Kazuo, Iwamoto Machiko and Maruyama Naoki.
    International Journal of Plant Physiology and Biochemistry. Vol.3(3),pp.28-33,March 2011------------------
    1,Tianli Medical Institute 2,Tokyo Metropolitan Institute of Gerontology,Reseach Team for Functional---- genomics.


    http://www.academicjournals.org/article/article1380030204_Shinji%20et%20al.pdf 
【Presentations at academic conferences】
  1. “老化におけるサーファクタント異常産生機序に関する研究(第1報)-1%コレステロール負荷肺におけるクララ細胞の超微形態とBAL中の界面活性物質の変動について-”. 第21回日本臨床電子顕微鏡学会総会ならびに学術講演会. 神戸,1989,p.155.
     鄭珩楊少毅,小林洋,広畑泰久,潘杰,相原薫.日本医科大学中央電子顕微鏡研究施設,WHO電顕診断学研究研修協力センター.
  2. “Endotoxin誘発肝不全症に対するAmi-Z10の栄養学的評価に関する研究”.第21回日本臨床電子顕微鏡学会総会ならびに学術講演会. 神戸,1989, P.122.
     広畑泰久,小林洋,潘杰,鄭珩,相原薫.日本医科大学中央電子顕微鏡研究施設,WHO電顕診断学研究研修協力センター.
  3. “動脈硬化性心病変の進展とその予防に関する研究(第2報)”.日本病理学会会誌.vol.78,東京,1989,p.231.
     鄭珩,小林洋,潘杰,広畑泰久,M. Ghazizadeh,楊少毅,相原薫,孫泰重*,M. Reike**.  日本医科大学中央電子顕微鏡研究施設;韓国慶北大学病理*;
  4. “動脈硬化性心疾患の進展とその予防に関する研究(第3報)高コレステロール食負荷心における植物性アルカロイド反復性投与の影響について”.日本病理学会会誌.vol.79,no.1,東京,1990,p.151.
     鄭珩,小林洋,潘杰,広畑泰久,M. Ghazizadeh,相原薫. 日本医科大学中央電子顕微鏡研究施設.
  5. “肺動脈硬化性病変の発生機序解明と肺動脈炎との関係について(第2報)”.日本病理学会会誌.vol.79,no.1,東京,1990,p.111.
     潘杰,小林洋,鄭珩,広畑泰久,M. Ghazizadeh,相原薫. 日本医科大学中央電子顕微鏡研究施設.
  6. “東大病院における過去36年間の骨腫瘍・腫瘍様病変の生検・手術例の病理学的検討”.日本病理学会会誌.vol.81,no.1,東京,1992p.286.  段建方,諸傑,鄭珩,堀内啓,田中文彦,町並陸生.東京大学医学部病理学教室.
  7. "Identification of EBV-latently infected lymphocytes in HIV infected lymphonodes". AIDS Research Newsletter, Tokyo, 1993, p.62.
     Heng Zheng, Shigeo Mori. Dept. of Pathol, Inst. of Med. Sci. Univ. of Tokyo, Japan.
  8. “Identification of EBV-Transformed Lymphocytes in HIV-Infected Lymphnodes”. Tenth International Conference on AIDS, International Conference on STD. Abstract Book. Vol. I, Yokohama, Japan, 1994, p.105.
     Heng Zheng, Shigeo Mori. Dept. of Pathol, Inst. of Med. Sci. Univ. of Tokyo, Japan.
  9. “悪性リンパ腫におけるbcl-2蛋白およびEB virusの発現と臨床所見との関連”.第36回日本臨床血液学会総会.東京.臨床血液.vol.35,no.10,1994,p.1135.
     井上靖之,澤登雅一,鈴木憲史,榎本英壽,武村民子*.日赤医療センター血液内科,同病理*.鄭珩,森茂郎.東京大学医科学研究所病理.
  10. "Expression of latent membrane protein 1 (LMP1) in AIDS-related lymphomas and its animal models". AIDS Research Newsletter. Sapporo, Japan, 1994, p.125.
     Harutaka Katano, Yasuyuki Morishita, Lixin Cui, Heng Zheng, Shigeo Mori, Dept. of Pathol, Inst. of Med. Sci. Univ. of Tokyo, Japan.

天利の健康食品の特徴

  1. ナノテクノロジーで加工した製品は粒子が小さい、吸収が速い。
  2. 医学専門家が科学的な処方で開発した製品。
  3. 動物実験で証明された製品。
  4. 10年間の臨床使用実績及び8ヵ国の愛用者の信用を得ている製品。
  5. 日本及び米国で発明特許を取得した製品。